Correlative study on the expression of p53 and DNA ploidy in acute nonlymphocytic leukemia
- 23 Downloads
We used the flow cytometric immunoassay to study the correlation between the tumor-suppressor gene product p53− and the DNA ploidy in 30de novo cases of acute nonlymphocytic leukemia (ANLL). The results showed that 15 cases were negative and the other 15 cases were positive expression for p53. As compared with p53 negative (p53) cases, the patients with positive p53 (p53+) had higher percentage of bone marrow blasts and lower peripheral leukocyte and platelet counts, which had no influence on the complete remission rate. Before treatment, DNA diploidy was seen in 18 cases including 12 p53− cases, and DNA aneuploidy in 12 cases including 9 p53+. After therapy, aneuploidy could be transformed into diploidy. Patients with P53+ or having aneuploidy in complete remission were at risk for early relapse. We believe that p53 may be involved in the process of leukemogenesis and progression of ANLL.
Key wordsp53 tumor-suppressor gene DNA ploidy flow cytometry acute nonlymphocytic leukemia
Unable to display preview. Download preview PDF.
- 3.Zhang R X, Yao E G. The prognostic significance of flow cytometry DNA measurement in acute leukemia. Chin J Hematol, 1989, 10:415.Google Scholar
- 7.Qi F Y, Qing T W, Liu X Yet al. Study on the expression of ras oncogene product p21 and DNA ploidy in oral squamous cell carcinoma. Chin J Phy Med, 1993, 15:24.Google Scholar